Pharmacotherapy of bipolar disorder: The role of atypical antipsychotics and experimental strategies

Human Psychopharmacology

Volumn 17, Issue 8, 2002, Pages 407-412

  Malhi, Gin S ^a   Berk, Michael ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atypical antipsychotics; Bipolar disorder; Calcium channel blockers; Clozapine; Olanzapine; Omega 3 fatty acids; Quetiapine; Risperidone

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLOZAPINE; DONEPEZIL; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUPENTIXOL; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; LAMOTRIGINE; LITHIUM; NIMODIPINE; OLANZAPINE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PLACEBO; QUETIAPINE; RISPERIDONE; TAMOXIFEN CITRATE; VALPROIC ACID; VERAPAMIL; ZIPRASIDONE;

AGRANULOCYTOSIS; AKATHISIA; BIPOLAR DISORDER; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; TARDIVE DYSKINESIA; TREATMENT OUTCOME; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CALCIUM CHANNEL BLOCKERS; CLOZAPINE; DIBENZOTHIAZEPINES; HUMANS; PIRENZEPINE; RISPERIDONE;

EID: 0036902873     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.437     Document Type: Review

References (90)

1. Addonizio G. 1985. Rapid induction of extrapyramidal side effect with combined use of lithium and neuroleptics. J Clin Psychopharmacol 5: 296-298.
2. Ahlfors UG, Baastrup PC, Dencker SJ, et al. 1981. Flupenthixol decanoate in recurrent manic-depressive illness: a comparison with lithium. Acta Psychiatrica Scand 64: 226-237.
3. Baldessarini RJ, Frankenburg FR. 1991. Clozapine: a novel antipsychotic agent. N Engl J Med 325: 746-754.
4. Banov MD, Zarate CA, Jr, Tohen M, et al. 1994. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55: 295-300.
5. Barbini B, Scherillo P, Benedetti F, et al. 1997. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int J Clin Psychopharmacol 12: 109-112.
6. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. 2000. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 57: 95-97.
7. Berk M, Bodemer, Van Oudenhove T, Butkow N. 1995. The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Hum Psychopharmacol 10: 189-193.
8. Berk M, Ichim L, Brook S. 1999. Olanzapine compared to lithium in mania: a double-blind, randomized-controlled trial. Int Clin Psychopharmacol 14: 339-343.
9. Bhugra P, Gulati OD. 1996. Interaction of calcium channel blockers with different agonists in aorta from normal and diseased rats. Indian J Physiol Pharmacol 40: 109-119.
10. Biederman J, Lerner Y, Belmaker RH. 1979. Combination of lithium carbonate and haloperidol in schizoaffective disorder: a controlled study. Arch Gen Psychiatry 36: 327-333.
11. Burt T, Sachs GS, Demopulos C. 1999. Donepezil in treatment-resistant bipolar disorder. Biol Psychiatry 45: 959-964.
12. Bymaster FP, Calligaro DO, Falcone JF, et al. 1996. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96.
13. Calabrese JR, Kimmel SE, Woyshville MJ, et al. 1996. Clozapine for treatment refractory mania. Am J Psychiatry 153: 759-764.
14. Calabrese JR, Meltzer Hy, Markovitz PJ. 1991. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 11: 396-397.
15. Carman JS, Bigelow LB, Wyatt RJ. 1981. Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 42: 124-128.
16. Chacko RC, Hurley RA, Jankovic J. 1993. Clozapine use in diffuse Lewy body disease. J Neuropsychiatry Clin Neurosci 5: 206-208.
17. Chang KD, Ketter TA. 2000. Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 10: 45-49.
18. Chouinard G, Arnott W. 1993. Clinical review of risperidone. Can J Psychiatry 38(Suppl. 3): S89-S95.
19. Cohen BM, Lipinski JF, Altesman RI. 1982. Lecithin in the treatment of mania: double-blind, placebo-controlled trials. Am J Psychiatry 139: 1162-1164.
20. Degner D, Bleich S, Muller P, Jajak G, Adler L, Ruther E. 2000. Clozapine in the treatment of mania. J Neuropsychiatry Clin Neurosci 12: 283.
21. Dose M, Emrich HM, Cording-Tommel C, et al. 1986. Use of calcium antagonists in mania. Psychoneuroendocrinol (Oxford) 11: 241-243.
22. Dubovsky SL. 1986. Calcium antagonists: a new class of psychiatric drugs? Psychiatric Ann 16: 724-728.
23. Fitz-Gerald MJ, Pinkofsky HB, Brannon G, Dandridge E, Calhoun A. 1999. Olanzapine-induced mania. Am J Psychiatry 156: 1114.
24. Frazier JA, Meyer MC, Biederman J, et al. 1999. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 38: 960-965.
25. Frye MA, Altshuler LL, Bitran JA. 1996. Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol 16: 87-90.
26. Frye MA, Ketter TA, Altshuler LL, et al. 1998. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Dis 48: 91-104.
27. Fuchs DC. 1994. Clozapine treatment of bipolar disorder in a young adolescent. J Am Acad Child Adolesc Psychiatry 33(9): 1299-1302.
28. Garza-Trevino ES, Overall JE, Hollister LE. 1992. Verapamil versus lithium in acute mania. Am J Psychiatry 149: 121-122.
29. Gelenberg AJ, Hopkins HS. 1996. Antipsychotics in bipolar disorder. J Clin Psychiatry 57: 49-52.
30. Ghaemi SN, Katzow JJ. 1999. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 11: 137-140.
31. Ghaemi SN, Sachs GS. 1997. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 12: 333-338.
32. Ghaemi SN, Sachs GS, Baldassano, C, Truman CJ. 1997. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 42: 196-199.
33. Giannini AJ, Houser WL, Loiselle RH, et al. 1984. Antimanic effects of verapamil. Am J Psychiatry 141: 1602-1603.
34. Giannini AJ, Loselle RH, Price WA, et al. 1986. Comparison of antimanic efficacy of clonidine and verapamil. J Clin Pharmacol 25: 307-308.
35. Goodwin FK, Jamison KR. 1990. Manic-Depressive Illness. Oxford University Press: New York.
36. Green AI, Tohen M, Patel JK, et al. 2000. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 157: 982-986.
37. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. 1998. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 155: 1608-1610.
38. Grunze H, Walden J, Wolf R, et al. 1996. Combined treatment with lithium and nimodipine in a bipolar I manic syndrome. Progr Neuropsychopharmacol Biol Psychiatry 20: 419-426.
39. Guille C, Sachs GS, Ghaemi SN. 2000. A naturalistic comparison of clozapine, risperidone and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 9: 638-642.
40. Hoschl C, Kozeny J. 1989. Verapamil in affective disorders: a controlled, double-blind study. Biol Psychiatry 25: 128-140.
41. Jacobsen FM. 1995. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 56: 423-429.
42. Janicak PG, Newman RH, Davis JM. 1992. Advances in the treatment of manic and related disorders: a reappraisal. Psychiatric Ann 22: 92-103.
43. Janicak PG, Sharma RP, Pandey G, et al. 1998. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry 155: 972-973.
44. Kane JM. 1988. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 49: 12-14.
45. Keck PE, Jr, Ice K. 2000. A 3-week double-blind, randomized trial of ziprasidone in the acute treatment of mania [abstract]. Int J Psychopharmacol 3(Suppl. 1): S342.
46. Keck PE, Jr, Wilson DR, Strakowski SM, et al. 1995. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 56: 466-470.
47. Kimmel SE, Calabrese JR, Meltzer HY. 1993. Clozapine in treatment refractory mania (Abstract 21: 80). In 1993 CME Syllabus and Proceedings Summary American Psychiatric Association Annual Meeting, San Francisco, CA May 22-27, 1993. American Psychiatric Association: Washington, DC.
48. Lane HY, Lin YC, Chang WH. 1998. Mania induced by risperidone: dose related? J Clin Psychiatry 59: 85-86.
49. 2A receptor blockade. Pharmacopsychiatry 33: 38-41.
50. Leysen JE, Janssen PM, Megens AA, Schotte A. 1994. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 55(Suppl.): 5-12.
51. Licht RW, Bysted M, Christensen H. 2001. Fixed-dosed risperidone in mania: an open experimental trial. Int Clin Psychopharmacol 16: 103-110.
52. Lindenmayer JP, Klebanov R. 1998. Olanzapine-induced manic-like syndrome. J Clin Psychiatry 59: 318-319.
53. Malhi GS, Checkley SA. 1999. Olanzapine in the treatment of psychotic depression. Br J Psychiatry 174: 460.
54. Malhi GS, Mitchell P, Salim S. 2002. Bipolar depression management options. CNS Drugs 16(10): 653-670.
55. Marder SR, Meibach RC. 1994. Risperidone in the treatment of schizophrenia. Am J Psychiatry 151: 825-835.
56. McElroy SL, Dessain EC, Pope HG, Jr, et al. 1991. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 52: 411-414.
57. McElroy SL, Frye M, Denicoff K, et al. 1998. Olanzapine in treatment-resistant bipolar disorder. J Affect Dis 49: 119-122.
58. McElroy SL, Keck PE, Jr, Strakowski SM. 1996. Mania, psychosis and antipsychotics. J Clin Psychiatry 57: 14-26.
59. Mitchell P, Malhi GS. 2002. The expanding pharmacopea for bipolar disorder. Annu Rev Med 53: 173-188.
60. Muller-Spahn F. 1992. Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group. Clin Neuropharmacol 15(Suppl. 1 Pt A): 90A-91A.
61. Pazzaglia PJ, Post RM, Ketter TA, et al. 1993. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 49: 257-272.
62. Pazzaglia PJ, Post RM, Ketter TA, et al. 1998. Nimodipine monotherapy and carbamazapine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol 18: 404-413.
63. Puri BK, Taylor DG, Alcock ME. 1995. Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder. Br J Clin Pract 49: 333-334.
64. Richelson E. 1996. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 57(Suppl. 11): 4-11.
65. Schaller JL, Behar D. 1999. Quetiapine for refractory mania in a child. J Am Acad Child Adolesc Psychiatry 38: 498-499.
66. Schweitzer I. 2001. Does risperidone have a place in the treatment of nonschizophrenic patients? Int Clin Psychopharmacol 16: 1-19.
67. Segal J, Berk M, Brook S. 1998. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21: 176-180.
68. Stoll AL, Cohen BM, Snyder MB, Hanin I. 1991. Erythrocyte choline concentration in bipolar disorder: a predictor of clinical course and medication response. Biol Psychiatry 29: 1171-1180.
69. Stoll AL, Sachs GS, Cohen BM, Later B, Christensen JD, Renshaw PF. 1996. Choline in the treatment of rapid-cycling bipolar diorder. Biol Psychiatry 40: 382-388.
70. Stoll AL, Severus E, Freeman MP, et al. 1999. Omega-3 fatty acids in bipolar disorder. Arch Gen Psychiatry 56: 407-412.
71. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO. 1992. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 32: 270-280.
72. Suppes T, Webb A, Paul B, et al. 1999. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156: 1164-1169.
73. Taylor D, McConnell D, McConnell H, Kerwin R. 2001. Prescribing Guidelines, 6th edn. Martin Dunitz: London.
74. Tohen M, Jacobs TG, Grundy SL, et al. 2000. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 57: 841-849.
75. Tohen M, Sanger TM, McElroy, et al. 1997. Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients (NR206). In 1997 New Research Program and Abstracts, American Psychiatric Association 150th Annual Meeting, San Diego, CA. May 17-22. American Psychiatric Press: Washington.
76. Tohen M, Sanger TM, McElroy SL, et al., the Olanzapine HGEH Study Group. 1999. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 156: 702-709.
77. Tohen M, Todd M, McElroy SL, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 156: 702-709.
78. Tohen M, Zarate CA, Jr. 1998. Antipsychotic agents and bipolar disorder. Clin Psychiatry 59(Suppl. 1): 38-48.
79. Tohen M, Zarate CA, Jr, Centorrino F, et al. 1996. Risperidone in the treatment of mania. J Clin Psychiatry 57: 249-253.
80. Tohen M, Zarate CA, Jr, Zarate SB, et al. 1996. The McLean/Harvard First-Episode Mania Project: pharmacological treatment and outcome. Psychiatric Ann 26: 5444-5448.
81. Tollefson GD, Beasley CM, Jr, Tran PV, et al. 1997. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 154: 457-465.
82. Tran PV, Hamilton SH, Kuntz AJ, et al. 1997. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 17: 407-418.
83. Walton SA, Berk M, Brook S. 1996. Superiority of lithium over verapamil in mania: a randomized, controlled, single-blind trial. J Clin Psychiatry 57: 543-546.
84. Young LT, Walsh JJ, Kish SJ. 1994. Reduced brain 5HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 35: 121-127.
85. Zarate CA, Jr, Narendran R, Tohen M, et al. 1998. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 59: 24-28.
86. Zarate CA, Rothschild A, Fletcher KE, Madrid A, Zapatel J. 2000. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 61: 185-189.
87. Zarate CA, Jr, Tohen M. 2000. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 61: 33-38.
88. Zarate CA, Jr, Tohen M, Banov MD, et al. 1995. Is clozapine a mood stabilizer? J Clin Psychiatry 56: 108-112.
89. Zullino D, Baumann P. 1999, Olanzapine for mixed episodes of bipolar disorder. J Psychopharmacol 13: 198-201.
90. Zolezzi M, Badr MG. 1999. Risperidone-induced mania. Ann Pharmacother 33: 380-381.